Personal dose equivalent, H p (10) and H p (0.07) doses were measured using an ionization chamber and personal electric dosimeters to estimate the exposure dose for medical staff members and carers as received from 89 Sr therapy patients. The H p (10) for medical workers was measured using personal dosimeters and was found to be <1 μSv during the measurement period. H p (0.07) for medical workers did not exceed 5 μSv per case during routine work, although the dose on the patient's skin surface was about 20 times that on the medical staff. To investigate the contribution of electrons to the measured dose, the dose on the patient's skin surface as obtained from uniformly distributed 89 Sr in a similar MIRD phantom was calculated using EGS5 code. The peak energy of the incident photons was approximately 0.6 MeV. The estimated H p (10) and H p (0.07) doses for the medical staff were 0.43 and 91 μSv/h, respectively. The contribution of electrons to the calculated H p (0.07) was approximately 200 times that of photons. Thus, the high H p (0.07) for medical staff is attributed to the strong contribution of electrons.
Introduction
Sr is administered to patients with painful bony metastases [1] . The injected amount is 2 MBq/kg for an adult. This activity is sufficiently low to meet Japanese guidelines for releasing 89 Sr therapy patients from the hospital [2] . Thus, patients can return home soon enough. 89 Sr is a beta-emitter with energies of <1.5 MeV and half-life of 50.5 days [3] . 89 Sr injected in the blood is distributed not only in the bone but also throughout the body after several days, as estimated by calculations using Dose and Risk Calculation (DCAL) software (see Figure 1 ) [4] . The effective dose for a male adult in 89 Sr therapy is estimated to be about 3 mSv/MBq [5, 6] . However, the dose for the public is negligible because most electrons emitted from 89 Sr are absorbed in the patient's body and low-energy bremsstrahlung radiation is emitted outside the body, as observed by SPECT [7] .
The effective dose and skin dose received by the medical staff and carers from 89 Sr in a patient's body are also very low. However, the actual levels of H p (10) and H p (0.07) for medical staff and carers who approach these patients are not clear. These doses may be raised because of the influence of electrons and bremsstrahlung radiation emitted from a patient's skin surface.
In this study, the exposure dose of electrons to *Corresponding author. Email: sumi0704@fujita-hu.ac.jp medical staff such as doctors, nurses, and radiological technologists from an 89 Sr therapy patient was measured using an ionization chamber (IC) or personal electrical dosimeter. The effects of the measurement height, measurement detection, and elapsed time on the dose for medical staff were examined in the measurement results.
To estimate the contributions of electrons and photons to the skin dose of the medical staff as received from an 89 Sr source inside a patient, the energy fluences of incident electrons and photons in the region of interest on the body surface of a similar MIRD phantom were also calculated by the Monte Carlo simulation code EGS5. These calculation results were compared with the measured dose on a surface of a patient's body. Sr-laveled strontium chloride to a patient. The doses for a doctor, nurse, and radiological technologist involved in the administration of 89 Sr were measured using personal dosimeters (DOSE 3 , Chiyoda Technol Co.) during the treatment. After 1 h of bed rest by the patient and 4 days after discharge when the patient visits the hospital to get checked for the accumulation of 89 Sr, the radiological technologist usually measures H p (10) at the height of the xiphoid process (level 1) using an IC (ICS-315, ALOKA). In this study, the doses at the heights of the xiphoid process (level 1), abdomen (level 2), and bladder (level 3) of the patients were measured using the IC at that time to investigate the effects of the accumulation spots of the dose on a surrounding medical staff. The dose was also measured at the front, back, and right and left sides of the patients at these heights, as shown in Figure 3 . These objectives are to investigate the dose of the medical staff when they are close to medical staff.
Measurement and calculation methods

Measurement methods for medical staff's dose
The measurements were performed for seven patients aged between 39 and 77 years. Figure 2 . Flowchart of examination for administration of 89 Sr-labeled strontium chloride to a patient at a hospital.
Development of mathematical model
A similar simplified MIRD phantom used as a radiation source was developed to estimate the dose for the medical staff as received from the patient's entire body by the Monte Carlo simulation code EGS5. This phantom comprised a head, a trunk, arms, a skull, a spine, legs, ribs, a clavicle, arm bones, and leg bones. The body and tissues had the same size and density as the MIRD phantom [8] . However, lungs were not included in this phantom as a preliminary study because it was considered that only existing 89 Sr in an extremely surface soft tissue contributes to the energy spectra. The thickness of the skin, which had the same density as the soft tissue, was set as 0.02 cm.
In this calculation, 100 MBq of 89 Sr was distributed uniformly over the entire body under the skin of the phantom. The region of interest (ROI), which had dimensions of 10 cm Ф × 1 cm thickness, lay at the center of the front trunk surface of the phantom. The dose on the phantom's surface was calculated using the dose conversion coefficients in ICRP Publication 74 and the energy spectrum per particle fluence in the ROI. Figure 4 shows the geometry for the similar simplified MIRD phantom. The calculated results were compared with the measured results converted to the value when 100 MBq of 89 Sr is absorbed in the body. Sr-labeled strontium chloride to blood at each height of the patient body surface. All measured H p (10)/h on a patient's body surface were less than 1 μSv/h. The relative standard deviations (RSDs) were <70% of the mean value at the bladder height on the front side, because of the large difference in the accumulation rates of 89 Sr among individuals.
Results and discussion
Dose measured on patient surface
One hour after the injection of 89 Sr, the highest dose was measured at the height of the abdomen. The mean value of the front, left, right, and back was 0.79 μSv/h. The measured dose at the xiphoid process height was not very different from that measured at the abdomen height. The doses of the front and back sides were high. The RSD was about 20% of the mean value.
Four days after injection, the dose rates measured at most points were lower than those measured after 1 h. The dose rate on the front side of the abdomen height after 4 days was about 70% that after 1 h. This is because half of 89 Sr still remained in not only the bone but also the entire body, as shown in Figure 1 . Table 2 lists the ratio of decrease in H p (10)/h for patients with different accumulation points 4 days after the injection of 89 Sr to that after 1 h; these values were taken from the front of a patient's body surface at the xiphoid process height. The ratios of decrease in the dose measured at the front and left sides of the body were slower than those measured on the right and back sides. No clear difference was observed in the dose at a particular accumulation point in the case of differences in the uptake of radionuclides from the body sizes among individuals; this is discussed below. Figure 7 shows the relationship between the dose rate (H p (10)/h), the patient's injected amount and the BMI value. The dose rate decreased with increasing BMI. The correlation factor between H p (10) and the BMI was 0.58. This indicates that the injected 89 Sr spreads out and that individuals with higher BMI have higher absorption rates for the radiation. The dose for the individual with the highest BMI was twice that of the individual with the lowest BMI. Table 3 presents the dose equivalent for medical staff such as a doctor, nurse, and radiological technologist (H p (10) and H p (0.07)) as measured using personal dosimeters. H p (10) for the medical staff was lower than 1 μSv during treatment. H p (0.07) measured on the body surfaces of the doctors and nurses was lower than 5 μSv/episode, although the dose measured on the patient's skin surface was 32-267 μSv/case. The dose for radiological technologists was 3 μSv during the 89 Sr injection preparation period and 10 μSv during the dose measurement period. The measurement period was kept longer than usual in this study because the dose was measured in detail to examine its distribution in patients. Thus, the dose for the radiological technologist would be smaller and similar to that of the doctor and nurse in routine work. 
Measured dose for medical staff during 89 Sr therapy operation
Calculation of dose for similar MIRD phantom
The energy spectrum of particles deposited in the ROI set at the front of the phantom's body surface was calculated by EGS5 when the injected 89 Sr was uniformly distributed over the entire body. The contribution of particles emitted from 89 Sr in the head and leg to the deposition energy in the ROI located at the center of phantom's trunk was negligible. The incident electrons per occurring electron fluence had a broad peak, as shown in Figure 8 . The energy spectrum of photons had a peak at 0.06 MeV. This distribution was similar to the experimental results of Ota et al. [7] . Table 4 presents H p (10)/h and H p (0.07)/h calculated from the energy spectrum shown in Figure 8 . H p (10)/h was derived from only photons. The contribution of photons to H p (0.07)/h was small even though the number of incident photons in the ROI was an order of magnitude higher than that of electrons.
The calculated and measured dose rates are listed in Table 4 . The calculated results were within the SD of the measured results. Thus, the calculated results corresponded to the measured ones relatively well, although the differences among individuals were large in the measured results, as mentioned above. The calculated H p (0.07) was reduced to one-sixth when the phantom was covered by a 1 mm thick cellulose cloth. 
Conclusion
The doses H p (10) and H p (0.07) were measured 1 h and 4 days after the injection of 89 Sr to estimate the dose for medical staff involved in 89 Sr-therapy-related-work, such as a doctor, nurse, radiological technologist and carers.
The doses for the medical staff as received from the 89 Sr therapy patients and the contributions of electrons and photons to the dose were calculated by EGS5 using a similar MIRD phantom. The doses measured on the front sides of the abdomen and xiphoid process heights of the patient did not show much difference and were higher than that measured at the bladder height. Among the doses measured at the front, left, right, and back sides of the patient, the doses at the front tended to be high. Thus, the dose could be measured on the patient's front surface of the abdomen or xiphoid process height for obtaining a reasonable and conservative estimate of the dose for medical staff and carers. H p (10) measured at the patient's body surface and for the medical staff was lower than 10 μSv during treatment, although H p (0.07) at the patient's skin surface was a few orders of magnitude higher.
The calculated H p (10) and H p (0.07) at the phantom surface agreed with the measured results when the source of 89 Sr existed in the similar MIRD phantom. The calculated and measured H p (0.07) were higher than calculated and measured H p (10). The calculated energy fluence of the electrons was not as high as that of the photons. However, the dose calculated from these fluences suggests that the contribution of electrons to H p (0.07) at the patient's surface is 200 times that of photons. 
